March 21, 2023
AbbVie Inc. has agreed to pay $2.7 million to settle a whistleblower False Claims Act lawsuit accusing it of using unlawful kickbacks to encourage medical providers to prescribe its blockbuster drug Humira, according to a Tuesday filing in Illinois federal court.
March 18, 2021
AbbVie Inc. lost a bid on Thursday to have a single judge handle a pair of closely watched fraud cases over allegations that the company illegally marketed its drug Humira, with an Illinois federal judge ruling that reassignment would significantly delay a whistleblower's False Claims Act case before her.
March 16, 2021
AbbVie Inc. insisted Tuesday that its push for one judge to handle a pair of closely watched fraud cases has nothing to do with that judge rejecting kickback theories that another judge deemed viable, saying it merely desires consistency.
November 30, 2020
AbbVie Inc. on Monday partially beat a suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira when an Illinois federal judge limited the case to only Florida-related allegations.
November 01, 2018
AbbVie Inc. has urged an Illinois federal judge to let it escape a False Claims Act suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira through the use of a network of nurse "ambassadors."